Combined operative and radiochemotherapeutic concept in the treatment of pelvic wall recurrences of cervical cancer;Beckenwandrezidive des Zervixkarzinoms. Kombiniertes operativ- radiochemotherapeutisches vorgehen (CORCT)

Strahlentherapie und Onkologie

Volumn 174, Issue 5, 1998, Pages 279-283

  Schulz Wendtland, Rüdiger ^a,b   Krämer, Stefan ^a   Säbel, Manfred ^a   Heller, Franz ^a   Keilholz, Ludwig ^a   Jäger, Wolfram ^a   Sauer, Rolf ^a   Lang, Norbert ^a   Bautz, Werner ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Afterloading; Cervical cancer; Cisplatin; Exenteration; Radiochemotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL; IRIDIUM 192; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PATIENT SELECTION; PELVIS EXENTERATION; PROGNOSIS; RADIOISOTOPE THERAPY; SURVIVAL RATE; UTERINE CERVIX CANCER; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CLINICAL TRIAL; FOLLOW UP; MIDDLE AGED; MORTALITY; TUMOR RECURRENCE; UTERINE CERVIX TUMOR;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PELVIC EXENTERATION; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 0031595835     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03038722     Document Type: Article

References (21)

1. Bauer M, Schulz-Wendtland R, Ladner HA. Primäre Behandlung des Zervixkarzinoms: Gibt es Indikationen für die paraaortale Strahlentherapie? In: Teufel G, Pfleiderer A, Ladner HA, Hrsg. Therapie des Zervixkarzinoms. Berlin-Heidelberg-New York-London-Paris-Tokio-Hongkong: Springer, 1990:256-65.
2. Burke T, Hoskins W, Heller P, et al. Clinical patterns of tumor recurrence after radical hysterectomy in stage IB cervical carcinoma. Obstet Gynecol 1987;69:382.
3. Chung C, Nahhas W, Stryker J, et al. Analysis of factors contributing to treatment failures in stage EB and ILA carcinoma of the cervix. Am J Obstet Gynecol 1980;138:550.
4. Deutsch M, Parsons J. Radiotherapy for carcinoma of the cervix recurrent after surgery. Cancer 1977;34:2051.
5. Evans S Jr, Bilans B, Barber H. External vs. interstitial irradiation in unresectable recurrent cancer of the cervix. Cancer 1971;28:1284.
6. Friedman M, Pearlman A. Carcinoma of the cervix: radiation salvage of surgical failures. Radiology 1965;84:801.
7. Haas T, Buchsbaum H, Lifshitz S. Nonresectable recurrent pelvic neoplasm. Gynecol Oncol 1980;9:177.
8. Heller F, Bauer M, Jäger W, et al. PTFE-Halterungen für Nachladesonden in der postoperativen interstitiellen High-dose-Brachytherapie. Radiologe 1995;35:146.
9. Höcket M, Baußmann E, Mitze M, et al. Are pelvic side-wall recurrences of cervical cancer biologically different from central relapses? Cancer 1994;74:648.
10. Höckel M, Knapstein P, Hohenfellner R, et al. Die kombinierte operative und radiotherapeutiscbe Behandlung (CORT) von Beckenwandrezidiven: Erfahrungsbericht nach 3 Jahren. Geburtshilfe Frauenheilkd 1993; 53:169.
11. Höckel M, Vorndran B, Schlenger K, et al. Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix. Gynecol Oncol 1993;51:141-9.
12. Jobson J, Leer J, Cleton F, et al. Treatment of locoregional recurrence of carcinoma of the cervix by radiotherapy after primary surgery. Gynecol Oncol 1989;33:368.
13. Krebs H, Helmkamp F, Sevin B, et al. Recurrent cancer of the cervix following radical hysterectomy and pelvic node dissection. Obstet Gynecol 1982;59:422.
14. Munnell E, Bonney W. Critical points of failure in the therapy of cancer of the cervix. Am J Obstet Gynecol 1961;81:521.
15. Potter M, Alvarez R, Gay F, et al. Optimal therapy for pelvic recurrence after radical hysterectomy for early-stage cervical cancer. Gynecol Oncol 1990;37:74.
16. Rotmensch J, Senekjian EK, Javaheri G, et al. Evaluation of bolus cis-platinum and continuous 5-fluorouracil infusion for metastatic and recurrent squamous cell carcinoma of the cervix. Gynecol Oncol 1988;29:76-81.
17. Schulz-Wendtland R, Bauer M, Teufel T, et al. Zervixkarzinomrezidive und ihre Bedeutung an der Universitäts-Frauenklinik Freiburg in den Jahren 1976 bis 1985. Strahlenther Onkol 1991;167:82-88.
18. Schulz-Wendtland R, Krämer S, Heller F, et al. Behandlung von Beckenwandrezidiven mit Hilfe des CORCT-Verfahrens. Strahlenther Onkol 1995;171:40.
19. Schulz-Wendtland R, Krämer S, Keilholz L, et al. Dosisleistungseffekte an Ca-Ski- und HPK-Zellea in Abhängigkeit von Dosis und Fraktionierung. Strahlenther Onkol 1996;172:439-45.
20. Sommers G, Grigsby P, Perez C, et al. Outcome of recurrent cervical carcinoma following definitive irradiation. Gynecol Oncol 1989;35:150.
21. Webb M, Symmonds R. Site of recurrence of cervical cancer after radical hysterectomy. Am J Obstet Gynecol 1980;138:813.